日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

静脉注射C1抑制剂浓缩液用于遗传性血管性水肿长期预防的疗效和安全性

Craig, Timothy; Shapiro, Ralph; Vegh, Arthur; Baker, James W; Bernstein, Jonathan A; Busse, Paula; Magerl, Markus; Martinez-Saguer, Inmaculada; Riedl, Marc A; Lumry, William; Williams-Herman, Debora; Edelman, Jonathan; Feuersenger, Henrike; Machnig, Thomas; Rojavin, Mikhail

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

C1抑制剂浓缩液在≥65岁患有遗传性血管性水肿的成年人中的应用:来自国际Berinert®(C1-INH)注册研究的结果

Bygum, Anette; Martinez-Saguer, Inmaculada; Bas, Murat; Rosch, Jeffrey; Edelman, Jonathan; Rojavin, Mikhail; Williams-Herman, Debora

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

西格列汀在临床研究中的安全性和耐受性:一项纳入10246例2型糖尿病患者数据的汇总分析

Williams-Herman, Debora; Engel, Samuel S; Round, Elizabeth; Johnson, Jeremy; Golm, Gregory T; Guo, Hua; Musser, Bret J; Davies, Michael J; Kaufman, Keith D; Goldstein, Barry J

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis

西格列汀:胰腺炎发生率的临床前和临床数据综述

Engel, S S; Williams-Herman, D E; Golm, G T; Clay, R J; Machotka, S V; Kaufman, K D; Goldstein, B J

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

西格列汀治疗2型糖尿病患者的安全性和耐受性:一项汇总分析

Williams-Herman, Debora; Round, Elizabeth; Swern, Arlene S; Musser, Bret; Davies, Michael J; Stein, Peter P; Kaufman, Keith D; Amatruda, John M